PDCD1LG2 and neoplasm: On the other hand, PD-1 binds to its ligands, PD-L1 and PD-L2, on various cells, including APCs and tumor cells, leading to inhibition of TCR-mediated signaling and reduction of cytokine production and T-cell proliferation (46).